3-氨基-5-羧基苯硼酸 | 116378-40-6

• 分子结构分类: 有机化合物 - 苯类化合物 - 苯和取代衍生物
• 中文名称: 3-氨基-5-羧基苯硼酸
• 中文别名: 3-氨基-5-羧基L苯基硼酸
• 英文名称: (3-amino-5-carboxylphenyl)boronic acid
• 英文别名: 3-Amino-5-carboxyphenylboronic acid；3-amino-5-boronobenzoic acid；3-amino-5-dihydroxyboranyl-benzoic acid；3-Amino-5-dihydroxyboryl-benzoesaeure；3-amino-5-carboxylphenylboronic acid
• CAS: 116378-40-6
• 化学式: C₇H₈BNO₄
• mdl: MFCD02179466
• 分子量: 180.956
• InChiKey: VVQAAMZMJNXCOP-UHFFFAOYSA-N

物化性质

• 熔点：
  210-212
• 沸点：
  545.5±60.0 °C(Predicted)
• 密度：
  1.49±0.1 g/cm3(Predicted)

计算性质

• 辛醇/水分配系数(LogP)：
  0.37
• 重原子数：
  13
• 可旋转键数：
  2
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.0
• 拓扑面积：
  104
• 氢给体数：
  4
• 氢受体数：
  5

安全信息

• 危险性防范说明：
  P261,P264,P270,P271,P280,P301+P312,P302+P352,P304+P340,P330,P363,P501
• 危险性描述：
  H302,H312,H332

SDS

Material Safety Data Sheet

---

Section 1. Identification of the substance
3-Amino-5-carboxylphenylboronic acid
Product Name:
Synonyms: 3-Amino-5-boronobenzoic acid

---

Section 2. Hazards identification
Harmful by inhalation, in contact with skin, and if swallowed.
H315: Causes skin irritation
H319: Causes serious eye irritation
H335: May cause respiratory irritation
P261: Avoid breathing dust/fume/gas/mist/vapours/spray
Wear protective gloves/protective clothing/eye protection/face protection
P280:
P305+P351+P338: IF IN EYES: Rinse cautiously with water for several minutes. Remove contact lenses if present
and easy to do – continue rinsing
P304+P340: IF INHALED: Remove victim to fresh air and keep at rest in a position comfortable for breathing
P405: Store locked up

---

Section 3. Composition/information on ingredients.
3-Amino-5-carboxylphenylboronic acid
Ingredient name:
CAS number: 116378-40-6

---

Section 4. First aid measures
Immediately wash skin with copious amounts of water for at least 15 minutes while removing
Skin contact:
contaminated clothing and shoes. If irritation persists, seek medical attention.
Eye contact: Immediately wash skin with copious amounts of water for at least 15 minutes. Assure adequate
flushing of the eyes by separating the eyelids with fingers. If irritation persists, seek medical
attention.
Inhalation: Remove to fresh air. In severe cases or if symptoms persist, seek medical attention.
Wash out mouth with copious amounts of water for at least 15 minutes. Seek medical attention.
Ingestion:

---

Section 5. Fire fighting measures
In the event of a fire involving this material, alone or in combination with other materials, use dry
powder or carbon dioxide extinguishers. Protective clothing and self-contained breathing apparatus
should be worn.

---

Section 6. Accidental release measures
Personal precautions: Wear suitable personal protective equipment which performs satisfactorily and meets local/state/national
standards.
Respiratory precaution: Wear approved mask/respirator
Hand precaution: Wear suitable gloves/gauntlets
Skin protection: Wear suitable protective clothing
Eye protection: Wear suitable eye protection
Methods for cleaning up: Mix with sand or similar inert absorbent material, sweep up and keep in a tightly closed container
for disposal. See section 12.
Environmental precautions: Do not allow material to enter drains or water courses.

---

Section 7. Handling and storage
Handling: This product should be handled only by, or under the close supervision of, those properly qualified
in the handling and use of potentially hazardous chemicals, who should take into account the fire,
health and chemical hazard data given on this sheet.
Storage: Store in closed vessels.

---

Section 8. Exposure Controls / Personal protection
Engineering Controls: Use only in a chemical fume hood.
Personal protective equipment: Wear laboratory clothing, chemical-resistant gloves and safety goggles.
General hydiene measures: Wash thoroughly after handling. Wash contaminated clothing before reuse.

---

Section 9. Physical and chemical properties
Not specified
Appearance:
Boiling point: No data
Melting point: No data
Flash point: No data
Density: No data
Molecular formula: C7H8BNO4
Molecular weight: 181.0

---

Section 10. Stability and reactivity
Conditions to avoid: Heat, flames and sparks.
Materials to avoid: Oxidizing agents.
Possible hazardous combustion products: Carbon monoxide, nitrogen oxides.

---

Section 11. Toxicological information
No data.

---

Section 12. Ecological information
No data.

---

Section 13. Disposal consideration
Arrange disposal as special waste, by licensed disposal company, in consultation with local waste
disposal authority, in accordance with national and regional regulations.

---

Section 14. Transportation information
Non-harzardous for air and ground transportation.

---

Section 15. Regulatory information
No chemicals in this material are subject to the reporting requirements of SARA Title III, Section
302, or have known CAS numbers that exceed the threshold reporting levels established by SARA
Title III, Section 313.

---

SECTION 16 - ADDITIONAL INFORMATION
N/A

反应信息

• 作为反应物：
  描述：

  3-氨基-5-羧基苯硼酸 在 potassium acetate 、 sodium cyanoborohydride 、 caesium carbonate 、 O-(1H-benzotriazol-1-yl)-N,N,N',N'-tetramethyluronium hexafluorophosphate 、 三乙胺 作用下， 以 甲醇 、 二氯甲烷 、 水 、 二甲基亚砜 为溶剂， 反应 16.34h， 生成 (3S,4R,5R)-2-[[3-[3-[[(2S)-1-(dimethylamino)-3-phenylpropan-2-yl]carbamoyl]-5-[methyl-[2-(methylamino)-2-oxoethyl]amino]phenyl]-2-methoxyphenyl]methyl]-4-[(1S)-1-hydroxyethyl]-5-(hydroxymethyl)-N-[(1S,2S,3S,5R)-2,6,6-trimethyl-3-bicyclo[3.1.1]heptanyl]-1,2-oxazolidine-3-carboxamide
  参考文献：
  名称：

  Compounds and Methods for Inhibiting the Interaction of BCL Proteins with Binding Partners

  摘要：

  该发明涉及含有结合到Bcl蛋白并抑制Bcl功能的异氧杂环丙氨酸化合物。这些化合物可用于治疗和调节与过度增殖相关的疾病，如癌症。

  公开号：

  US20080114167A1
• 作为产物：
  描述：

  3-羧基苯硼酸 在 硫酸 、 palladium 10% on activated carbon 、 氢气 、 硝酸 作用下， 以 甲醇 为溶剂， 反应 6.5h， 生成 3-氨基-5-羧基苯硼酸
  参考文献：
  名称：

  吲哚并喹啉衍生物及其制备方法和应用

  摘要：

  本发明提供了吲哚并喹啉衍生物及其制备方法和在制备抗肿瘤、抗病毒药物中的应用。所述吲哚并喹啉衍生物的化学结构式如以下所示：式Ⅰ本发明还提供了吲哚并喹啉衍生物具体的制备方法。本发明经实验证明，本发明涉及的部分硼酸修饰的吲哚并喹啉衍生物以及无硼酸修饰的吲哚并喹啉衍生物对多种肿瘤细胞株具有强的抑制作用，可用于制备抗肿瘤药物。本发明涉及的部分硼酸修饰的吲哚并喹啉衍生物以及无硼酸修饰的吲哚并喹啉衍生物具有很强的抗病毒活性，可以用于制备抗病毒药物。

  公开号：

  CN103497211B

文献信息

• Universal Solid-Phase Approach for the Immobilization, Derivatization, and Resin-to-Resin Transfer Reactions of Boronic Acids
  作者：Michel Gravel、Kim A. Thompson、Mark Zak、Christian Bérubé、Dennis G. Hall

  DOI：10.1021/jo0106501

  日期：2002.1.1

  amides, anilides, and ureas, respectively. Ugi multicomponent reactions on DEAM-PS-supported aminobenzeneboronic acids, derivatization of multifunctional arylboronic acids, and sequential reactions can also be carried out efficiently. These new DEAM-PS-supported arylboronic acids can be employed directly into resin-to-resin transfer reactions (RRTR). This type of multiresin process helps eliminate time-consuming

  含硼酸的分子广泛用于生物学，医学和合成领域。然而，这些化合物往往难以通过溶液相方法处理。在此，该问题通过用于官能化硼酸的衍生化的第一种通用固相方法的开发来解决。该方法基于使用二乙醇胺树脂锚，该锚通过避免在酯化过程中彻底去除水的需要而促进了硼酸的固定。通过在室温下在无水溶剂中简单搅拌，可以在数分钟内将多种硼酸固定在N，N-二乙醇氨基甲基聚苯乙烯（DEAM-PS，1）上。通过（1）DEAM-PS负载的对甲苯基硼酸的（1）NMR分析显示了形成具有假定的NB配位的双环二乙醇胺硼酸酯的证据。通过紫外光谱研究了DEAM-PS树脂对相同型号硼酸的水解裂解。水解和附着显示在快速达到的平衡下发生，并且需要大量过量的水（> 32当量）以实现从DEAM-PS实际定量释放硼酸。尽管它们对水和醇具有相对的敏感性，但可以用甲酰基，溴甲基，羧基或氨基官能化的DEAM-PS结合的芳基硼酸以良好或极高的收率转化成各种胺，酰
• [EN] HETEROARYL COMPOUNDS AND THEIR USE AS THERAPEUTIC DRUGS<br/>[FR] COMPOSÉS HÉTÉROARYLE ET LEUR UTILISATION COMME MÉDICAMENTS THÉRAPEUTIQUES
  申请人：DONG-A SOCIO HOLDINGS CO LTD

  公开号：WO2017039331A1

  公开（公告）日：2017-03-09

  The present invention provides heterocyclic compounds, the stereoisomer thereof, the enantiomer thereof, or the pharmaceutically acceptable salt, which are capable of modulating the activity of Mer receptor tyrosine kinase (MERTK). This invention also provides pharmaceutical compositions thereof, methods to prepare the said compounds, and the use of such compounds as a medicament. The present invention is directed to MERTK inhibitory compounds with marked potency, thereby having an outstanding potential for a pharmaceutical intervention of cancer and any other diseases related to MERTK dysregulation.

  本发明提供了一种杂环化合物、其立体异构体、对映异构体或药用可接受的盐，这些化合物能够调节Mer受体酪氨酸激酶（MERTK）的活性。本发明还提供了这些化合物的药物组合物、制备所述化合物的方法以及将这些化合物用作药物的应用。本发明针对的是具有显著活性的MERTK抑制性化合物，因此具有在癌症和任何与MERTK调控失调相关的疾病中进行药物干预的卓越潜力。
• Compounds and methods for inhibiting the interaction of BCL proteins with binding partners
  申请人：Castro C. Alfredo

  公开号：US20070155705A1

  公开（公告）日：2007-07-05

  The present invention relates to heterocyclic compounds that bind to Bcl proteins and inhibit Bcl function, compositions comprising such compounds, and methods for treating and modulating disorders associated with hyperproliferation, such as cancer.

  本发明涉及结合到Bcl蛋白并抑制Bcl功能的杂环化合物，包括这些化合物的组合物，以及用于治疗和调节与高增殖相关的疾病，如癌症的方法。
• [EN] PHTHALAZINE DERIVATIVES AS PHOSPHODIESTERASE 4 INHIBITORS<br/>[FR] DERIVES DE PHTHALAZINE UTILISES COMME INHIBITEURS DE LA PHOSPHODIESTERASE 4
  申请人：ZAMBON SPA

  公开号：WO2004056366A1

  公开（公告）日：2004-07-08

  Compounds of formula I wherein R and R1 are as defined in the description.The compounds of formula I are PDE 4 inhibitors.

  式I中的化合物，其中R和R1如描述中所定义。式I的化合物是PDE 4抑制剂。
• Boronic acid adducts of metal dioxime complexes useful in labelling
  申请人：E. R. Squibb & Sons, Inc.

  公开号：US05183653A1

  公开（公告）日：1993-02-02

  Boronic acid adducts of metal dioxime complexes are useful as reagents for labeling proteins and other amine-containing compounds.

  硼酸加合物的金属双肟配合物对于标记蛋白质和其他胺基化合物非常有用。